| Financial Year |
March 31 2023 |
| Monetary Funds |
1,610,018,788.70 |
| Held-for-trading Financial Assets |
2,601,726.51 |
| Notes Receivable |
3,224,719.52 |
| Accounts Receivable |
56,572,497.42 |
| Advances to Suppliers |
14,183,482.23 |
| Other Receivables |
10,672,219.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
327,366,547.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,573,647.51 |
| Total Current Assets |
2,168,366,166.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,555,097.50 |
| Investment Properties |
159,973,783.51 |
| Fixed Assetes |
783,302,483.47 |
| Under-construction Projects |
363,253,416.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
306,261,040.37 |
| R&D expenses |
126,734.24 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
35,461,519.90 |
| Other Non-Current Assets |
6,175,477.40 |
| Sub-Total of Non-Current Assets |
1,886,658,099.62 |
| Total Assets |
4,055,024,265.67 |
| Short-Term Loans |
116,736,435.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
329,266,366.18 |
| Accounts Received In Advance |
162,026.77 |
| Employee Compensation Payable |
55,916,658.09 |
| Taxes Payable |
44,045,797.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,347,935.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,373,311.13 |
| Other Current Liabilities |
4,773,712.66 |
| Sub-Total of Current Liabilities |
651,577,197.09 |
| Long-term Loans |
16,181,224.61 |
| Bonds Payable |
514,686,000.10 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,375,617.05 |
| Deferred Income Tax Liabilities |
32,798,024.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
632,116,958.82 |
| Total Liabilities |
1,283,694,155.91 |
| Paid-In Capital(Or Share Stock) |
424,230,053.00 |
| Capital Surplus |
54,336,264.64 |
| Surplus Reserve |
276,864,943.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,724,856,676.70 |
| Minority Stockholder's Interest |
123,645,231.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,647,684,878.45 |
| Owner's Equity（Stockholder's Equity） |
2,771,330,109.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,055,024,265.67 |
